N Kanesa thasan

Summary

Affiliation: Walter Reed Army Medical Center
Country: USA

Publications

  1. ncbi Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers
    N Kanesa-Thasan
    Walter Reed Army Institute of Research, Washington, DC, USA
    Vaccine 19:3179-88. 2001
  2. ncbi Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission
    S B Halstead
    Medical Science and Technology Division, Office of Naval Research, Arlington, Virginia 22217-5660, USA
    Am J Trop Med Hyg 65:180-3. 2001
  3. ncbi Short report: absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines
    N Kanesa-Thasan
    Walter Reed Army Institute of Research, Washington, District of Columbia 20307 5100, USA
    Am J Trop Med Hyg 66:115-6. 2002
  4. ncbi Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines
    N Kanesa-Thasan
    Walter Reed Army Institute of Research, Washington, District of Columbia, USA
    Am J Trop Med Hyg 69:17-23. 2003
  5. ncbi Atypical antibody responses in dengue vaccine recipients
    N Kanesa-Thasan
    Walter Reed Army Institute of Research, Washington, District of Columbia, USA
    Am J Trop Med Hyg 69:32-8. 2003
  6. ncbi Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3' noncoding sequences
    H S Houng
    Department of Virus Diseases, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA
    J Virol Methods 95:19-32. 2001

Collaborators

Detail Information

Publications6

  1. ncbi Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers
    N Kanesa-Thasan
    Walter Reed Army Institute of Research, Washington, DC, USA
    Vaccine 19:3179-88. 2001
    ..The live attenuated tetravalent dengue vaccine was most reactogenic, and preferential replication of dengue-3 virus may have affected its infectivity and immunogenicity...
  2. ncbi Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission
    S B Halstead
    Medical Science and Technology Division, Office of Naval Research, Arlington, Virginia 22217-5660, USA
    Am J Trop Med Hyg 65:180-3. 2001
    ..These observations, which are reminiscent of those in Africa, provide further evidence of a dengue resistance gene in black populations...
  3. ncbi Short report: absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines
    N Kanesa-Thasan
    Walter Reed Army Institute of Research, Washington, District of Columbia 20307 5100, USA
    Am J Trop Med Hyg 66:115-6. 2002
    ..Vaccination against JE or dengue is unlikely to prevent WN virus infection but may still protect against disease...
  4. ncbi Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines
    N Kanesa-Thasan
    Walter Reed Army Institute of Research, Washington, District of Columbia, USA
    Am J Trop Med Hyg 69:17-23. 2003
    ..Subsequent studies with more recipients will further establish safety and immunogenicity of the four selected vaccine candidates: DENV-1 45AZ5 PDK 20, DENV-2 S16803 PDK 50, DENV-3 CH53489 PDK 20, and DENV-4 341750 PDK 20...
  5. ncbi Atypical antibody responses in dengue vaccine recipients
    N Kanesa-Thasan
    Walter Reed Army Institute of Research, Washington, District of Columbia, USA
    Am J Trop Med Hyg 69:32-8. 2003
    ..02). Yellow fever virus priming broadens the antibody response to monovalent DENV vaccination. The effect of flavivirus priming on the clinical and immunologic response to tetravalent DENV vaccine remains to be determined...
  6. ncbi Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3' noncoding sequences
    H S Houng
    Department of Virus Diseases, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA
    J Virol Methods 95:19-32. 2001
    ..By analyzing sera samples from Puerto Rico that were collected from 1999 through 2000, the assay demonstrated high level detection sensitivity and specificity of 92.8 and 92.4%, respectively, for all four dengue virus serotypes...